A retrospective study evaluating the impact of infectious complications during azacitidine treatment
Crossref DOI link: https://doi.org/10.1007/s00277-017-3001-2
Published Online: 2017-05-04
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schuck, Anna
Goette, Marie-Christine
Neukirchen, Judith
Kuendgen, Andrea
Gattermann, Norbert
Schroeder, Thomas
Kobbe, Guido
Germing, Ulrich
Haas, Rainer
Funding for this research was provided by:
Celgene
Novartis Pharma
Janssen-Cilag
License valid from 2017-05-04